Phase II/III Clinical Trial To Treat Cerebral Palsy Using Autologous Adult Stem Cells

RNL BIO CO LTD has announced the filing of an Investigational New Drug application with the Korean Food and Drug Administration to initiate clinical trials phase II and III assessing the company's RNL-Astrostem stem cell drug in patients with cerebral palsy.

http://www.science20.com/news_articles/phase_iiiii_clinical_trial_treat_cerebral_palsy_using_autologous_adult_stem_cells-103238